Digipharm

Digipharm

@CharyOno98

DIGIPHARM

Digipharm brings together industry expertise, mature concepts and revolutionary blockchain technologies to facilitate the transformation of health care into a value-based approach.


The cost of spiral health combined with resource constraints has resulted in an unrelenting burden on the health system. Negotiations should be made, patients at risk of rejected innovative treatments and there are still barriers to reimbursement for producers.

Digipharm passed the limitations of infrastructure to enable the implementation of flexible value-based pricing agreements using smart contracts, the development of an unprecedented platform of evidence and the ability to reward patients for the contribution of their data.

Our vision

To pioneer the delivery of sustainable and value-based health services,

generation of innovative evidence and patient empowerment across the health care industry.

The Future of Health Care


  • Values Based Care

Health care systems around the world today are threatened by unique challenges in our day; unsustainable spending, an aging population and an increasing prevalence of chronic diseases. Value-based health concepts propose that payments for health care should be linked to the quality of care and benefits it provides; switch from 'cost for service' to 'cost-for-performance' replacement model.

  • Innovative Price

Innovative pricing solutions such as value-based pricing offer an increasingly dynamic solution to address the uncertainty surrounding the relative costs of treatment relative to patient outcomes. Such mechanisms reward manufacturers and providers for improving patient outcomes, incentivize innovation and drive the transition to patient-centered healthcare.

  • Generation of Pioneer Evidence

Innovative proof generation solutions are required to meet relevant, timely and quality data needs to inform optimized value-based health services delivery. Avoiding the use of static or retrospective data will open the horizons for superior forecasting, confidence in decision making and global oversight related to current developments in increasingly dynamic industries such as healthcare.

The Digipharm Difference


Elimination of Obstacles

While value-based health services provide solutions to the various problems faced by the health care system, the use of a broad-based value-based approach has been hampered by the limitations of current health information system infrastructure, administrative burden of implementation and fragmentation of health care delivery and patient outcome data.

Patient Empowerment

Digipharm is a strong believer in empowering patients with the care and ownership of their personal data. Patients will be given incentives to share and contribute their health-related data to inform decision-making and health-related research.


Blockchain Technology

The Digipharms solution will facilitate and accelerate paradigm shifts to value-based healthcare and patients using 'smart contracts' and blockchain technologies. Utilizing blockchain technology for the Digipharms platform promotes the development of an ubiquitous, transparent and secure decentralized health information infrastructure.


Our Excellence Solutions

Reimbursement will remove infrastructure barriers and automate the implementation of value-based pricing agreements, no matter how complex, on fully independent global platforms; encourage personal health technology change on a fee for performance basis for the benefit of patients, payers and producers.

  • Speed up access to high cost therapies
  • Encourage innovation
  • Drastically reduce administrative costs

Insight is a place of real evidence of a 'live' world and allows the utilization of real-world evidence (RWE) as soon as it is available. The availability of 'live' RWE will provide stakeholders with real-time intelligence that they can inform decision-making and product development throughout the drug's lifecycle.

  • Incentives for patients to contribute data
  • Significant cost savings compared to conventional RWE sources
  • Single platform for global proof

Our Team


Ahmed Abdulla


Founder/CEO


Girisha Fernando


Co-Founder/COO


Zach Daniels


CTO


Ralf Gerteis


Commercial Strategy


Alexander Sverdlov


Cybersecurity Strategy


Meredith Darden


Digital Marketing Lead


Alexey Popov


Web Development


Michael Gubert


UI/UX Design



Leon Rebolledo


Lead Architect



Rolf Günter


Legal Counsel



Bobby Kaura


Business Development


Dr. Mohamed Abdulla


Clinical Transformation



Dr. Hasham Al-Meshhedani


Patient Engagement


Ali Al-Sudani


Clinical Pharmacist



Dr. Rami Radwan


Clinical Relations



Peter Sandbach


Communications Director



Debra De Silva-Sun


HEOR & Pricing Analyst



Marko Granic


Graphic Designer



Our Advisors

Sven Möller


ICO Advisor

Swisscom Blockchain AG


Kamal Youssefi


Enterprise Blockchain Advisor

Swisscom Blockchain AG


Waldemar Scherer


Life Sciences Blockchain Advisor

Swisscom Blockchain AG


Sam Mantle


Health & Life Sciences Technology Advisor

Luxoft


Daniel Heller


PR Advisor

Partner, Farner Consulting AG


Claudio Staub


Co-Head Startup Communications

Farner Consulting AG


Anas Aman


Quality and Testing

IBM


Lloyd Jefferies


CRM Advisor

KPMG


Per-Olof Thuresson


Health Economist

Roche


Fadi Chehadah


Health Economist

NICE UK


For more information and join social media DIGIPHARM please follow some sources for reference:


Website: https://www.digipharm.ch/

Whitepaper: https://digipharm.ch/docs/DigipharmWP.pdf

Twitter : https://twitter.com/DigipharmTeam

Facebook: https://www.facebook.com/digipharmteam/

Medium: https://medium.com/@digipharm

Telegram: https://t.me/joinchat/ExOHxk-TuOplQDbBWXaLaQ

Youtube: https://www.youtube.com/channel/UCtZuSfZBVdKErQtbO9Ql4Pg

LinkedIn: https://www.linkedin.com/company/11360677/

Reddit: https://www.reddit.com/r/Digipharm


===============================

Author: Mbladur

Bitcointalk Profile: https://bitcointalk.org/index.php?action=profile;u=1809638

Report Page